Galapagos | GLPG - Ebit

Aktienkurs
28.68
Täglich Wechseln
0.20 0.70%
Monatlich
-1.10%
Jährlich
20.81%
Q1 Prognose
27.05




Ebit Veränderung Datum
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 157M 2025-09
Genmab DKK 432M 900.27M 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Merck EUR 474M 738M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 502M 168M 2024-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12